[PDF] Top 20 A smartphone application for treating depressive symptoms: study protocol for a randomised controlled trial

... The therapeutic component of HeadGear encourages the user to complete one ‘challenge’ each day (5–10 min per day), over 30 days. These ‘challenges’ incorporate a variety of evidence-based BAT and mindfulness tech- niques ... See full document

... a smartphone app + telephone conference call (CBIA + TCC) This group will receive, in addition to CBIA as described above, a telephone contact in group format (in groups of five caregivers approximately), using a ... See full document

... five controlled trials have evalu- ated psychologically-informed interventions delivered by primary care practitioners (generally nurses) ...one study [14] has compared non-specialists with specialists ... See full document

... the study received ethical approval from the Research Ethics and Integrity subcommittee at Goldsmiths, University of London (application reference: EA ...the study is volun- tary, that participants ... See full document

... of depressive symptomatology is assessed with the Center for Epidemiologic Studies Depression Scale- Revised (CESD-R) [59, ...measures symptoms of depression in nine different categories: sadness (dys- ... See full document

... a randomised controlled trial (RCT) in which 244 young people aged 16-25 are randomly allocated to the Grip op Je Dip (GOJD) online group course or to a waiting list control ...of depressive ... See full document

... on treating a full-blown disorder, while sub-clinical PD is highly pre- valent and can develop into full-blown ...This study is a randomised controlled trial aimed to evaluate an ... See full document

... of depressive disorders with about one third ...developing smartphone-based behavioral activation interventions might be a way to develop a cost-effective treatment for people suffering from major ... See full document

... the trial will be invited to attend these follow-up visits for measure- ...research study may be stored indefinitely and used by our research group for future ... See full document

... the trial will be invited to attend these follow-up visits for measure- ...research study may be stored indefinitely and used by our research group for future ... See full document

... We will recruit 190 adults from the general population who report depressive symptoms (defined as a score ≥ 14 on the BDI-II). Approximate timings of the screening day procedures are presented in Table 1. ... See full document

... This study will give a first indication of EMA reactivity on depressive ...sive symptoms would limit EMA as an instrument, be- cause a change in EMA ratings might be attributed to the EMA itself ... See full document

... pilot trial of minocycline added to treatment as usual for patients suffering from DSM-IV major depressive ...double-blind, randomised, controlled, two parallel-arm study with 20 ... See full document

... The Ethics Commission at Babeș-Bolyai University has approved this study. Although the intervention that it delivers cannot be considered a treatment for depressed people, it does target individuals with mod- ... See full document

... The hypotheses will be tested with mixed effects linear regression analyses in Mplus6. Because adolescents are nested within groups and groups are nested within loca- tions, a three-level analysis is most appropriate to ... See full document

... clinical psychopathology. Participants included those who had experienced a myocardial infarction (MI), a revascularisation procedure (coronary artery bypass grafting [CABG] or percutaneous coronary intervention [PCI]), ... See full document

... The primary outcome measure is the change in the RSI score from baseline to the 4-month assessment. We be- lieve a clinical effect of 0.4 (equivalent to a difference in change of RSI of 3.1 given a standard deviation of ... See full document

... the trial at vari- ous gestations, including the fact that both using and not using lactate measurement are both common strat- egies at RWH and are accepted as appropriate by senior clinical ...the trial ... See full document

... Hormone replacement therapy (HRT) is a highly effective treatment for hot flushes, reducing incidence by up to 90% [4]. However, HRT also increases the risk of thrombo- embolic disease [9], stroke [10], breast cancer ... See full document

... The underlying biological pathogenesis of mastitis is im- portant when considering management options. Mastitis is characterised by the presence of the main aetiological agents of infection, staphylococci and ... See full document